Aurobindo Pharma Share: Europe mein Kamaal, US mein Thodi Giraavat, par Profit 2% Badha!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Aurobindo Pharma Share: Europe mein Kamaal, US mein Thodi Giraavat, par Profit 2% Badha!
Overview

Aurobindo Pharma ne Q4 mein **2%** profit badha kar **₹921 crore** kar diya hai. Europe mein sales **30.2%** badiya, lekin US mein **13%** kam hui. Fir bhi, company ne **9 ANDA** approvals liye aur cash position strong rakhi.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Europe ki Performance ne Aurobindo ko Di Badi Lehhar!

Aurobindo Pharma ke latest results bata rahe hain ki Europe mein toh bhai ne dhamaal macha diya hai, lekin US market mein thodi dikkat aa rahi hai. Company ka Net Profit 2% badh kar ₹921 Crore ho gaya hai. Overall revenue bhi 5.6% badhkar ₹8,853.3 Crore ho gaya.

Europe se toh revenue 30.2% badiya hai, ₹2,795 Crore tak pahunch gaya, aur saal bhar ki sales €1 billion cross kar gayi. Europe ki yeh badhiya performance Aurobindo ke liye ekdum zabardast hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.